As the market expands and approved options increase, companies should expect closer review of promotional messaging, partner relationships, and patient-facing communications.
They have not undergone the FDA's review for safety, effectiveness, or manufacturing quality as finished formulations - the review that every FDA-approved branded drug must pass
Traditional, accessed July 30, 2025, Spread Pricing 101 The National Community Pharmacists Association | NCPA, accessed July 30, 2025, Cignas 2023 Revenue Grew 8% to $195.3 Billion, accessed July 30, 2025, CVSs Health Services Revenue Grew to $186.8 Billion, accessed July 30, 2025, Ross, Colleagues Introduce Bipartisan PBM Reform Package | Press Releases, accessed July 30, 2025, The year of PBM reform: Pharmacy policy progress across the states , accessed July 30, 2025, Pharmaceutical Rebates: Their Impact and Value Explained incentX, accessed July 30, 2025, Five Top Drugmakers Reveal List vs
If you click on a link and make a purchase, we may receive a small commission at no extra cost to you
